摘要
目的：探讨莫沙必利在小儿消化不良治疗中的应用。方法选取2013年9月～2014年10月我院接诊的42例消化不良的患儿，按照入院的先后顺序实验组和对照组，实验组给予莫沙必利药物，对照组给予多潘立酮药物，观察两组患儿的治疗效果。结果实验组患儿的治疗总有效率高于对照组，差异有统计学意义（P〈0.05）；实验组患儿不良反应的发生率低于对照组，差异有统计学意义（P〈0.05）。结论莫沙必利在治疗小儿消化不良的效果显著，能够有效提高患儿的治愈率，降低不良反应的发生率，加快患儿的恢复。
Objective Discusse the effect of Mosapride in treatment of children patients with dyspepsia. Methods Chose 42 children patients with dyspepsia who were treated in hospital from September 2013 to October 2014 and separate them into study group and control group according to their hospitalization sequence. Patients in study group were given Mosapride treatment,while patients in control group were given Domperidone medicine treatment,and compared the treatment efficacy of these two groups. Results The treatment efficacy in study group was higher than control group,there was a treatment differential between the two groups,and such a differential has statistic value（P〈0.05）.In addition,the side-effect incidence of patients in study group were lower than control group,there was a treatment differential between the two groups,and such a differential has statistic value（P〈0.05）. Conclusion Mosapride medicine is of efficiency in treatment of children patients with dyspepsia, it is conducive to improving children patients’curing rate and reducing side-effect incidence in order to facilitate the recovery of children patients.
出处
《中国卫生标准管理》
2015年第7期184-185,共2页
China Health Standard Management
